tm logo
FULTRANSA
Live/Pending
SECOND EXTENSION - GRANTED

granted

on 04 Mar 2024

Last Applicant/ Owned by

One Johnson & Johnson Plaza

New Brunswick

NJ

08933

Serial Number

97271823 filed on 17th Feb 2022

Registration Number

N/A

Correspondent Address

Danielle R. Weitzman

Johnson & Johnson

One Johnson & Johnson Plaza

New Brunswick,NJ 08933

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

FULTRANSA

Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory disRead More

Classification Information


Class [005]
Pharmaceutical Products


Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

Mark Details


Serial Number

No 97271823

Mark Type

No Service/Collective Mark

Attorney Docket Number

No T36608US3

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
05th Mar 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04th Mar 2024SOU TEAS EXTENSION RECEIVED
04th Mar 2024SOU EXTENSION 2 FILED
04th Mar 2024SOU EXTENSION 2 GRANTED
01st Sep 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
30th Aug 2023SOU TEAS EXTENSION RECEIVED
30th Aug 2023SOU EXTENSION 1 FILED
30th Aug 2023SOU EXTENSION 1 GRANTED
07th Mar 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10th Jan 2023PUBLISHED FOR OPPOSITION